Cardinal Health (CAH) Beats on Q2 Earnings, Ups '24 EPS View
Cardinal Health's (CAH) second-quarter fiscal 2024 results benefit from the Pharmaceutical segment's solid performance.
Compared to Estimates, Cardinal (CAH) Q2 Earnings: A Look at Key Metrics
The headline numbers for Cardinal (CAH) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street es...
Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?
Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Cardinal Health lowers medical unit profit forecast, shares fall
Cardinal Health lowered the full-year profit forecast for its medical segment on Thursday, taking the shine off the company's upbeat second-quarter results and sending its shares down more than 5%.
Cardinal Health (CAH) Tops Q2 Earnings and Revenue Estimates
Cardinal Health (CAH) came out with quarterly earnings of $1.82 per share, beating the Zacks Consensus Estimate of $1.56 per share. This compares to earnings of $1.32 per share a year ago.
Cardinal Health to buy Specialty Networks for $1.2 billion in cash to boost analytics capabilities
Cardinal Health Inc. CAH, +0.73% announced Wednesday an agreement to buy Specialty Networks for $1.2 billion in cash. Cardinal said the acquisition expands its offering in therapeutic areas by boos...
What's in Store for Cardinal Health (CAH) in Q2 Earnings?
Cardinal Health's (CAH) second-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical segment.
Cardinal Health, Inc. (CAH) J.P. Morgan 42nd Annual Healthcare Conference (Transcript)
Cardinal Health, Inc. (CAH) J.P. Morgan 42nd Annual Healthcare Conference (Transcript)
Cardinal Health's stock rises in range of a record after upbeat profit outlook
Shares of Cardinal Health Inc. CAH, -0.52% rallied 1.7% in premarket trading Tuesday, after the drug distributor said it expects fiscal 2024 earnings to be at the high-end of previous guidance. The...
5 Low-Leverage Stocks to Buy Amid Mixed Investor Sentiments
The crux of safe investment lies in choosing a company that is not burdened with debt, as a debt-free stock is almost impossible to find. You may buy LOB, MAR, CAH, FN and WING.
Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2024 on February 1
DUBLIN, Ohio , Jan. 2, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2024 on February 1, prior to the opening of trading on...
Will My Portfolio's Top 3 Performing Stocks From 2023 Deliver Again in 2024?
Because buying dividend stocks is such a successful investment strategy over the past 100 years I gravitate towards them in my portfolio. It means I also look for stocks that have a proven track re...
Cardinal Health Is Setting Up For A Great 2024
Cardinal Health is a global healthcare company that operates in over 40 countries and covers pharmaceutical distribution and medical products. Based on strong Q1 earnings, the Company is growing on...
Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue?
Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Reasons to Add Cardinal Health (CAH) to Your Portfolio Now
Cardinal Health (CAH) continues to gain traction from a solid pharmaceutical segment and a diversified product portfolio. However, the rising cost of products is a concern.
Related Companies